adar poonawalla news
Latest from adar poonawalla
Adar Poonawalla speaks out on work-life balance: 'Can't go beyond 8-9 hours'
The Serum CEO said that meeting people and building relationships, for charity or networking purposes, is as crucial as office hours.
Updated on Jan 23, 2025 12:43 PM IST
Poonawalla Fincorp CTO quits, blames HR official: ‘Harassment, interventions’
Dhiraj Saxena wrote in the resignation letter that he could not manage the IT function efficiently because of the HR officer's action.
Published on Dec 08, 2024 12:59 PM IST
Karan Johar says Adar Poonawalla is ‘a dear, dear family friend for many years’
It was recently announced that billionaire businessman Adar Poonawalla’s Serene Productions will invest ₹10 billion in Karan Johar’s Dharma Productions.
Updated on Nov 15, 2024 10:47 AM IST
HT Entertainment Desk | Written by Devansh Sharma
Dharma-Serene deal spotlights stress in showbiz
Adar Poonawalla's Serene Productions invests ₹1,000 crore in Karan Johar's Dharma Productions amid challenges in India's film industry, signaling potential restructuring.
Updated on Nov 01, 2024 06:06 AM IST
Shuchi Bansal
Revenue down 50%: Dharma's poor finances made KJo sell stake?
As Adar Poonawalla acquires 50% stake in Dharma Productions, the company's finances indicate Karan Johar may have been forced into this deal.
Updated on Nov 07, 2024 04:52 PM IST
Abhimanyu Mathur
Meet Cyrus Poonawalla, Pune's richest man with a net worth of ₹2,04,300 crore
The ninth richest billionaire in the country, Poonawalla boasts a home worth ₹750 crore
Published on Oct 27, 2024 12:18 PM IST
Karan Johar helps raise ₹2.5 crore at Tata Memorial Hospital charity event
Karan Johar recently joined designer Maheka Mirpuri's MCAN Charity Gala. The filmmaker urged people to be more empathetic towards underprivileged patients.
Published on Oct 23, 2024 03:41 PM IST
Karan Johar, Adar Poonawalla put up united front at Manish Malhotra Diwali bash
A day after selling a 50% stake in his banner Dharma Productions to Adar Poonawalla, Karan Johar arrived with the businessman at a Diwali party.
Published on Oct 23, 2024 07:58 AM IST
Adar Poonawala on buying stake in Dharma productions: ‘My friend Karan Johar...’
Adar Poonawalla is acquiring a 50% stake in Karan Johar's Dharma Productions for 1000 crore, allowing Johar to maintain creative control.
Updated on Oct 21, 2024 01:53 PM IST
Karan Johar makes Adar Poonawalla Dharma Productions' co-owner, sells 50% stake
Adar Poonawalla acquires 50% stake in Karan Johar's Dharma Productions for ₹1000 crore, outpacing Reliance and Saregama.
Updated on Oct 21, 2024 03:17 PM IST
Poonawalla Fincorp taps HDFC Bank's Arvind Kapil as new MD & CEO. Who is he?
Appointment of Arvind Kapil as MD & CEO at Poonawalla Fincorp follows retirement of Abhay Bhutada, who will remain as non-executive director.
Published on Mar 18, 2024 07:19 PM IST
Why rich Indians are buying marquee properties in London
Ultra-high net-worth individuals exploring the UK as an investment destination often have great cultural comfort and familiarity with the place.
Published on Dec 18, 2023 11:09 AM IST
Adar Poonawalla strikes a deal to buy London’s most expensive house of the year
Adar Poonawalla has agreed to pay the amount for a 25,000 square foot Mayfair mansion.
Updated on Dec 12, 2023 10:36 PM IST
RIL tops list of Indian companies, Serum Institute first among unlisted: Report
The Top 10 companies in India hold ₹71.5 lakh crore, accounting for 37% of GDP. 7 of them are headquartered in Mumbai. Here is the list:
Published on Jun 20, 2023 05:58 PM IST
Bombay HC restrains activists from posting defamatory content on SII, Covishield
The order was passed in an interim application filed by SII in a defamation suit seeking ₹100 crore in damages from social media influencers Yohan Tengra and Ambar Kori for allegedly posting objectionable content regarding Covishield
Updated on Jun 05, 2023 03:28 PM IST
Serum Institute of India to produce 5mn Covishield doses in two months
SII has made available five to six million Covovax doses even as the demand for it is still almost zero. We will produce the same amount of Covishield doses in the next two to three months, said Adar Poonawalla
Updated on Apr 22, 2023 11:01 PM IST
WATCH: SII chief Adar Poonawalla on vaccine availability, current Covid strain
SII chief Adar Poonawalla on Saturday said that the current Covid strain is not severe and the company has produced five to six million doses of Covovax.
Published on Apr 22, 2023 03:08 PM IST
Covovax vaccine will get approval in next 10-15 days, says SII CEO Poonawalla
Covovax will be approved as a booster dose against Covid-19 and will be effective against the virus's Omicron variant, Adar Poonawalla said.
Published on Jan 09, 2023 12:13 PM IST
ANI | | Posted by Lingamgunta Nirmitha Rao
'Thank you for saving us': Devendra Fadnavis to Adar Poonawalla. His reply
Adar Poonawalla's Serum Institute of India is the world's biggest vaccine maker.
Updated on Jan 08, 2023 10:33 PM IST
Swati Bhasin, New Delhi
'Rising Covid cases in China concerning,' says Serum Institute's Adar Poonawalla
Expressing concern over the spurt in Covid-19 cases in China, former Indian diplomat KP Fabian on Tuesday said, "over 60 per cent of China and 10 per cent of the world population is likely to be infected with Covid and millions may die."
Updated on Dec 21, 2022 04:50 PM IST
ANI | | Posted by Yagya Sharma
Serum Institute Whatsapp duping case: Seven held from various states
As per the First Information Report registered with Bundgarden police station in the second week of September, the accused had used Poonawalla's image in a Whatsapp account and sent messages about money transfer to Satish Deshpande, one of the directors of the firm.
Published on Nov 25, 2022 07:32 PM IST
PTI |
SII's Adar Poonawalla expects Omicron-specific vaccine in 6 months: Report
Adar Poonawalla's statement came even as the UK became the first country to authorise an updated version of Moderna's Covid-19 vaccine that includes protection against the Omicron variant.
Published on Aug 15, 2022 11:36 PM IST
HT News Desk, New Delhi
Monkeypox: As India sees rise in cases, what Adar Poonawalla said about vaccine
India has so far reported eight cases of monkeypox, of which five have been from Kerala and three from Delhi. Of the five patients in Kerala, one succumbed to the disease on July 30, making it India's first monkeypox fatality.
Published on Aug 02, 2022 05:41 PM IST
Written by Sharangee Dutta | Edited by Aniruddha Dhar, New Delhi
SII to manufacture India’s 1st vaccine against cervical cancer after DGCI nod
Cervical cancer is the second most frequent cancer among women in India between the ages of 15 and 44.
Published on Jul 12, 2022 10:48 PM IST
Written by Harshit Sabarwal | Edited by Sohini Goswami, New Delhi
Poonawalla appeals to utilize learnings from Covid to strengthen health systems
The learnings from the global pandemic would help in addressing inequity in the health systems that are prevalent currently, Poonawalla said.
Published on May 23, 2022 11:16 PM IST
PTI |
Adar Poonawalla to Elon Musk on Tesla in India: 'Best investment you'll make…'
After a spell of uncertainity, Elon Musk last month was successful in clinching a $44 billion deal to buy Twitter.
_(1)_1651995399930_1651995418375.jpg "Adar Poonawalla in a rare post reached out to Elon Musk on Twitter.")
Published on May 08, 2022 01:01 PM IST
Adar Poonawalla clarifies Covovax available for everyone above 12 years
On Tuesday, Poonawalla announced that children in the age group of 12 to 17 years can get the Serum Institute of India's (SII) Covid-19 vaccine Covovax.
Published on May 05, 2022 08:51 AM IST
Written by Manjiri Sachin Chitre | Edited by Poulomi Ghosh
Covovax gets govt nod for 12-18 age group at private centres
On April 29, the National Technical Advisory Group on Immunisation (NTAGI)--the government’s technical panel--recommended inclusion of Covovax in the vaccination programme for children aged 12 and above.
Published on May 03, 2022 11:37 PM IST
'Covovax now available for children in India', says Adar Poonawalla, hails Modi
Serum Institute of India (SII) director for government and regulatory affairs Prakash Kumar Singh had written to the Centre recently requesting for Covovax's inclusion in the immunisation drive for children aged 12 to 17 years.
Updated on May 10, 2022 07:57 PM IST
HT News Desk, New Delhi
Made in India Covid vaccines better than Pfizer, Moderna: SII's Adar Poonawalla
Speaking to ANI, Poonawalla said, "The Covid-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like Pfizer and Moderna."
Published on Apr 13, 2022 04:22 PM IST
ANI |